Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:BIO)

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Business Wire 1 day ago

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

GlobeNewswire 7 days ago

Bio-Rad's Chief Operating Officer Andrew Last to Retire

Business Wire 9 days ago

Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer

Business Wire March 20, 2024

Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day

Business Wire February 22, 2024

Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results

Business Wire February 15, 2024

Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024

Business Wire January 24, 2024

Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 42nd Annual Healthcare Conference

Business Wire January 2, 2024

Bio-Rad Reports Third-Quarter 2023 Financial Results

Business Wire October 26, 2023
View More News ››

Opinion & Analysis (NYSE:BIO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:BIO)

Bio-Rad to Report First Quarter 2024 Financial Results on Tu

BREAKING NEWS: $BIO Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024Bio-Rad Laboratories, Inc. (NYSE: BIO...
whytestocks - 22 hours ago

Cell Analysis Market Analysis 2022: Industry Report

According to IMARC Group’s latest report, titled "Cell Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity...
edwardebreen15 - August 19, 2022

SZLS

https://www.stagezerolifesciences.com/prostate-health-index.html
FacBine - September 25, 2019

ODOR CONTROL - FOR MJ

https://www.ftmig.com/resources/matica-and-yunify-develop-first-new-consumer-product/
crude - November 7, 2018
View more Bullboard ››

Enerev5 Metals Inc

Enerev5 Metals Inc

Enerev5 Metals Inc. is a Canadian resource company. The Company is focused on the exploration and development potential ...
View More »